AIIMS director Dr Randeep Guleria Monday asked people to refrain from categorising the fungal infections based on its colour. He said people should rather use the medical names of the diseases instead, like Mucormycosis.
Dr Guleria was addressing the daily Covid-19 press conference. He stresses that it will be better if Mucormycosis is called by its name rather than its colour.
Dr Guleria also maintains that people developing warning signs of Mucormycosis should immediately consult doctors and seek treatment.
“90-95 per cent of patients getting Mucormycosis were either diabetic or were using steroids during their Covid-19 recovery.
There are several types of fungal infections like candida, aspergillosis, cryptococcus, histoplasmosis and coccidioidomycosis. Mucormycosis, candida and aspergillosis are the ones observed more in those with low immunity,” Guleria added.
The cases of Mucormycosis are a major cause of concern for the Centre and states. Also, the disease has a mortality rate of 50 per cent if untreated.
The second wave of COVID-19 has been devastating for India. Few parts of the country saw the resurgence of COVID-19-induced ‘black fungus’ cases.
This contagious contamination makes numerous patients lose their eyesight. Individuals contract this infection by coming in contact with the fungal spores in their environment.